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Arachidonic acid mediates the 
formation of abundant alpha-
helical multimers of alpha-
synuclein
Marija Iljina1, Laura Tosatto1,†, Minee L. Choi2, Jason C. Sang1, Yu Ye1,3, Craig D. Hughes4, 
Clare E. Bryant4, Sonia Gandhi2 & David Klenerman1
The protein alpha-synuclein (αS) self-assembles into toxic beta-sheet aggregates in Parkinson’s 
disease, while it is proposed that αS forms soluble alpha-helical multimers in healthy neurons. Here, we 
have made αS multimers in vitro using arachidonic acid (ARA), one of the most abundant fatty acids in 
the brain, and characterized them by a combination of bulk experiments and single-molecule Fӧ rster 
resonance energy transfer (sm-FRET) measurements. The data suggest that ARA-induced oligomers 
are alpha-helical, resistant to fibril formation, more prone to disaggregation, enzymatic digestion and 
degradation by the 26S proteasome, and lead to lower neuronal damage and reduced activation of 
microglia compared to the oligomers formed in the absence of ARA. These multimers can be formed at 
physiologically-relevant concentrations, and pathological mutants of αS form less multimers than wild-
type αS. Our work provides strong biophysical evidence for the formation of alpha-helical multimers of 
αS in the presence of a biologically relevant fatty acid, which may have a protective role with respect to 
the generation of beta-sheet toxic structures during αS fibrillation.
The aggregation of alpha-synuclein protein (α S) into amyloid fibrils is implicated in Parkinson’s disease (PD), 
Dementia with Lewy Bodies (DLB) and other synucleopathies1. Fibrils of α S are the major constituents of insol-
uble deposits, Lewy bodies and Lewy neurites, found in the brains of PD and DLB patients2. Moreover, small 
oligomers of α S formed early during the process of fibril formation are believed to represent the most toxic forms 
of this protein that cause irreversible neuronal damage3–5.
Apart from being disease-related, α S is also highly abundant in healthy brain tissue and constitutes around 
1% of the total brain proteins6. While in the pathogenic aggregates α S acquires beta-sheet conformation, its 
normal physiological state remains a subject of debate and active research. It has been demonstrated to be 
either purely monomeric in human tissue7 and neuronal cells8, or to form alpha-helically folded tetramers and 
related multimers9–12. In the brain, α S is localized to presynaptic nerve terminals in close proximity to synaptic 
vesicles13, and is involved in the transmission of vesicular cargo14, as well as vesicle trafficking and retrieval15. 
These processes occur via phospholipid membrane-based mechanisms16–19, implying a connection between the 
normal function of α S in healthy neurons with phospholipids and fatty acids (FAs). Furthermore, α S shares struc-
tural homology with the family of fatty acid binding proteins and is able to bind FAs20. Arachidonic acid (ARA) 
is a polyunsaturated FA and is one of the most abundant FAs in gray matter phospholipids in the human brain21. 
ARA is continuously released from the phospholipid membranes into the cytosol of brain neurons by the action 
of enzymes22, where it may co-exist with α S. Several in vitro studies have observed that ARA was able to promote 
the self-assembly of α S into a range of aggregates under various incubation conditions23–26.
Alpha-helically-folded multimers of α S, identified in living cells, have been difficult to prepare in vitro due to 
their dynamic nature27 and scarce information on other potentially required stabilizing factors, such as membrane 
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binding28. A rapid change of α S from unstructured to alpha-helical conformation was observed in the presence 
of ARA26 and related fatty acids29, upon interaction with lipid membranes30, detergent micelles31 and lipid 
vesicles32–34. However, to date, it has not been possible to characterize the formation of small alpha-helically folded 
multimers at physiologically-relevant concentrations, owing to the low abundance of these species and the diffi-
culties in contrasting them to the disease-related oligomers. To address this, we prepared alpha-helically-folded 
multimers of α S in the presence of ARA, and compared them to the toxic oligomers of α S using single-molecule 
Fӧ rster resonance energy transfer (sm-FRET) measurements. We present a set of comparative assays to investi-
gate the differences in the stabilities of both types of aggregates.
Results
Single-molecule FRET experiments. The main technique employed in this work is single-molecule 
FRET (sm-FRET). This highly sensitive method is particularly suitable for the characterization of the oligomers 
of α S, typically present in solutions in low abundance and in a vast excess of monomeric protein. In our previous 
related studies, this method was utilized to characterize the formation of oligomers during the aggregation of α S 
in aqueous solution in unprecedented detail35–38. Moreover, the sm-FRET method was further improved by per-
forming the measurements under steady flow, which allowed to observe the formation of oligomers of α S with 
higher time resolution36. This latter improvement enabled to study a rapid self-assembly of α S in the presence of 
ARA in this study.
For sm-FRET experiments, full-length α S protein was used, and an alanine to cysteine mutation was intro-
duced at residue 90 (A90C). This allowed the attachment of a single fluorophore, Alexa Fluor (AF) dye, per pro-
tein molecule. The mutation was demonstrated not to significantly affect the aggregation properties of α S in our 
previous studies35–38, because the residue 90 is located at the periphery of the beta-sheet core. For all sm-FRET 
aggregation assays, 1:1 stoichiometric ratio of α S labeled with Alexa Fluor 488 (α S-AF488) and Alexa Fluor 594 
(α S-AF594) was used, and ARA was unlabeled. The solutions were incubated, and aliquots were withdrawn 
and immediately diluted to picomolar concentrations of the protein, allowing the analysis in single-molecule 
regime, before being flowed through a microfluidic channel and irradiated with a focused 488 nm laser beam, 
as described previously36. Subsequently, the fluorescence signal was recorded separately in the AF488 (donor) 
and the AF594 (acceptor) channels. The 488 nm beam directly excites α S-AF488 molecules. Thus, α S-AF488 
monomers are observed in the experiment as single fluorescence bursts in the donor channel, whereas α S-AF594 
monomers remain undetected. Since oligomers contain both α S-AF488 and α S-AF594 molecules, the directly 
excited α S-AF488 non-radiatively excites the α S-AF594 via FRET process. Oligomers are therefore observed as 
simultaneous fluorescence intensity bursts in both the donor and the acceptor channels (Supplementary Fig. 1), 
and thus are distinguished from the excess of the monomeric protein in solution, and the numbers of detected 
oligomers are determined. In this method, the fluorescence intensity values of the oligomeric bursts were used 
to derive a FRET efficiency value for each oligomer (equation 1 in Methods), and its apparent size (equation 2 
in Methods). The FRET efficiency values of oligomers are related to their compactness, while the determination 
of the apparent sizes allows monitoring the growth of aggregates over time, as well as excluding larger fibrillar 
species, as described in detail in Methods.
The presence of ARA results in a rapid self-assembly of αS in solution. The self-assembly of α S 
was monitored in solutions of 35 μ M α S in the presence of 1 mM concentration of ARA, above the critical micel-
lar concentration (CMC) of the acid26,39. The samples were incubated under quiescent conditions, either in the 
presence or in the absence of ARA. Since the aggregation of pure α S in physiological buffer is known to be inef-
ficient at quiescent conditions in vitro40, the oligomerization at 35 μ M concentration of α S in the absence of ARA 
was negligible, and only a small increase in the numbers of detected oligomers was observed over a 24-hour incu-
bation (Fig. 1a). In contrast, 35 μ M α S incubated with 1 mM ARA showed a rapid formation of oligomers, judged 
by the presence of high levels of detected FRET events, recorded shortly after the addition of ARA (Fig. 1a). We 
confirmed the absence of any background fluorescence from the ARA solution in buffer. In addition, there was no 
apparent effect of ARA on the fluorescence signal from the fluorophores in the sm-FRET experiments, which was 
confirmed by performing control measurements using dual-labeled (AF488 and AF594) 40-base pair DNA sam-
ples, as detailed in Supplementary Fig. 2. Therefore, the initial rise in coincident events upon the addition of ARA 
to α S solution was due to the self-assembly of α S into multimers, which we will further refer to as ‘ARA-induced 
oligomers’. The increase in the numbers of these species continued most rapidly for 6 hours, followed by a plateau 
and a subsequent slight decrease after 20 hours (Fig. 1a), which could be due to a partial disaggregation of the 
species or, alternatively, due to their higher-order association. In addition to the rise in the numbers of multim-
ers with time, there was an identifiable increase in their average apparent sizes, observed from the broadening 
of the apparent size distributions (Fig. 1b). Typically, there was a progression towards larger species within first 
6–7 hours of the experiment, and no subsequent change, suggesting that their formation reached a steady state 
within this time period.
Circular dichroism (CD) measurements showed that the fluorescently labeled α S was intrinsically disordered 
in the absence of ARA at the beginning of the experiment, and acquired beta-sheet conformation after 24 hours 
of incubation, particularly in the samples incubated under shaking conditions, which overall indicated that the 
labeled protein could assemble into fibrils as in our previous works35,38. In contrast, the spectra of the samples in 
the presence of ARA were characteristic of alpha-helical conformation shortly upon addition of ARA, and after 
24 hours of incubation. The observed attainment of alpha-helical conformation by α S in the presence of ARA is in 
agreement with previously reported results for α S with ARA26, as well as for α S in the presence of the excess of a 
structurally similar docosahexaenoic acid29. Generally, the transition from the disordered to alpha-helical state is 
typical for α S upon its association with lipid membranes16,18, and suggests that α S binds ARA at our experimental 
conditions. To check whether the formation of α S oligomers, promoted by ARA, occurred when shear forces were 
www.nature.com/scientificreports/
3Scientific RepoRts | 6:33928 | DOI: 10.1038/srep33928
introduced, we performed incubations with shaking as well as under quiescent conditions, which yielded compa-
rable results at the same starting concentrations of α S and ARA (Fig. 1d). The quiescent preparation using 35 μ M 
α S and 1 mM ARA was found to be the most high-yielding among other tested preparations, including incuba-
tions using different isoforms of α S or varying concentrations of both α S and ARA, as detailed in Supplementary 
Methods and Supplementary Figs 3 and 4.
Further evidence for the differences between ARA-induced oligomers and oligomers formed 
in its absence. Once the ARA-induced oligomers of α S were observed, we sought to compare these mul-
timers to the toxic oligomers of α S which are formed by the protein in aqueous buffer. Using sm-FRET, we 
previously demonstrated that α S assembles into toxic beta-sheet-rich oligomers in aqueous buffer under con-
stant agitation35,36,38. Therefore, here we used the same strategy as before to prepare these α S-only oligomers (see 
Supplementary Information for details), and carried out a series of comparative experiments using ARA-induced 
oligomers and α S-only oligomers.
Firstly, we found using transmission electron microscopy (TEM) that the ARA-induced oligomers had mark-
edly different morphologies compared to the oligomers of α S formed in aqueous buffer (Fig. 2). In the case of α S 
samples in buffer solution, after 24 hours of incubation the solutions contained a mixture of monomers, soluble 
oligomeric species as well as insoluble fibrils (Fig. 2a). The majority of the insoluble fibrils could be removed by 
centrifugation, as judged by TEM and confirmed in our previous work38, therefore this step was introduced for 
the preparation of the α S-only oligomers. In the case of the samples with ARA-induced oligomers, abundant pop-
ulations of oligomers were observed, frequently associated into higher-order assemblies (Fig. 2b). Interestingly, 
these aggregates were soluble, judged from the absence of fibrillar aggregates in TEM images and no precipitate 
upon centrifugation of the samples. In the absence of α S, at 1 mM ARA, micelles were formed (Fig. 2c). In the 
presence of the protein, however, the aggregates visualized using TEM were smaller compared to the micellar 
structures, which is consistent with the previously reported observation that α S is able to disrupt the micelles 
Figure 1. Effect of ARA on αS. (a) Kinetic profile of α S aggregate formation induced by ARA at quiescent 
conditions, and of α S aggregation in pure buffer under quiescent conditions (n = 3, std). (b) Time evolution of 
the apparent size histograms indicating growth of the aggregates. (c) CD spectra of α S-AF594 with and without 
ARA. Without the acid, at 0 h protein is mostly in random-coil conformation, and contains beta-sheet structure 
after 24 h with shaking, indicated by a broad negative band at 217 nm. In the presence of ARA, both shortly after 
addition and after 24 h of incubation, CD spectra show the features corresponding to the alpha-helical state, 
negative bands at 208 nm and 221 nm. (d) Kinetic profile of aggregate formation of 35 μ M α S in the presence of 
1 mM ARA under either shaking or non-shaking conditions (n = 3). Comparable results suggest the absence of 
the effect of shaking on the kinetics in the presence of ARA.
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of ARA26. Overall, ARA-induced oligomers were larger and had less regular shapes than the α S-only oligomers, 
probably due to the association with the FA, and had a tendency to assemble into higher-order soluble agglomer-
ates. They looked similar in morphology to the previously reported oligomers of α S in the excess of docosahex-
aenoic acid29.
Having determined by TEM that ARA-induced oligomers had different morphologies compared to α S-only 
oligomers, we further investigated the differences between these types of species (Fig. 3). Firstly, a closer inspec-
tion of the FRET efficiency histograms revealed clear differences (Fig. 3a). As it has already been mentioned, 
using sm-FRET method we previously characterized the oligomerization process of α S in buffer solution in great 
detail35–38. In these previous studies, we reproducibly observed the conversion of initially formed disordered 
oligomers of α S to a more stable and compact form, associated with the highest cytotoxicity. These two types of 
oligomers could be distinguished based on their FRET efficiency values (eq. 1). While the initially formed dis-
ordered oligomers had low FRET efficiency values, and thus termed ‘low-FRET’, the stable toxic oligomers had 
characteristic high FRET efficiency values, and were termed ‘high-FRET’ oligomers. Here, the FRET efficiency 
histograms obtained for the samples of α S-only oligomers were in good agreement with the previous results. As 
in previous studies, after 9 hours of incubation mainly disordered oligomers were present with the mean FRET 
efficiency value E = 0.4, whereas after 24 hours the majority of the population contained the stable oligomers 
with high FRET values, E = 0.6. In contrast, ARA-induced oligomers gave rise to FRET efficiency histograms 
that showed a single peak with E value of 0.5 after 9 hours of incubation, and a broad FRET distribution after 
24 hours. Since the appearance of FRET efficiency histograms was found to be well-correlated with the stability of 
oligomeric aggregates in our previous work35, the observed differences of the FRET efficiency histograms of the 
ARA-induced multimers compared to α S oligomers in buffer solution could suggest differences in their stabili-
ties, and possibly differences in their structures. In addition, α S oligomers formed in the presence of ARA were 
found to be larger in terms of average numbers of monomers per oligomer, particularly at later incubations times 
past 6 hours of incubation, as shown in Fig. 3b.
Figure 2. TEM images of aggregates. (a) α S aggregates in buffer (35 μ M, 24 h, shaking). From left to right: 
before centrifugation (15 min at 14.2 r.p.m.), a mixture of oligomers and fibrils is observed; soluble oligomers are 
present in the supernatant after centrifugation; insoluble pellet after centrifugation contains fibrillar aggregates. 
Scale bars (left to right) 200 nm, 200 nm and 100 nm. (b) ARA-induced oligomers of α S (35 μ M, 1 mM ARA, 
24 h, non-shaking). No fibrils observed after centrifugation. Abundant soluble oligomers and oligomer 
agglomerates are present. Scale bars 100 nm (left) and 50 nm (right). (c) ARA acid micelles in buffer (1 mM 
ARA) in the absence of α S. Scale bars 1 μ m (left) and 100 nm (right).
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To explore whether these differences in the FRET histograms and apparent size distributions of the 
ARA-induced oligomers compared to α S-only oligomers were associated with the differences in oligomer stabil-
ities, we carried out more comparative experiments. In our previous work, it was found that the high-FRET oli-
gomers were more stable with respect to dilution into low ionic strength buffer in comparison to their preceding 
disordered oligomers. We therefore compared the stability of ARA-induced multimers and α S-only (high-FRET) 
oligomers to the changes in ionic strength. Samples were diluted into buffers with varying ionic strength and the 
numbers of oligomers in solution were counted using sm-FRET. The result showed that the α S-only high-FRET 
oligomers prepared in buffer were stable with respect to the changes in ionic strength, which agreed with our 
previous results. In contrast, ARA-induced oligomers dissociated to a greater extent at low ionic strengths, which 
is probably due to the lack of a beta-sheet structure in these species.
Next we investigated whether the lower structural stability of ARA-induced α S oligomers could facilitate 
their enzymatic degradation. The 26S proteasome is the main protein degradation machinery in eukaryotic cells, 
including degradation of α S monomers upon modification by ubiquitin41, yet it was reported to be inactive to 
Figure 3. Comparative sm-FRET experiments to investigate the differences between ARA-induced 
oligomers and oligomers formed in aqueous buffer during 24 h of incubation. (a) Appearance and time 
evolution of FRET efficiency histograms. Fits to eq. 3, with FRET eficiency values (E) of E(α S 9h) = 0.4± 0.01, 
E(α S 24h) = 0.57± 0.01, E(α S ARA 9h) = 0.52± 0.01, E(α S ARA 24h) = 0.301± 0.003 and 0.48± 0.03.  
(b) Comparison of apparent size distributions. (c) Salt gradient measurements (n = 3, std). (d) Degradation by 
26S proteasome over 12 h (n= 3, std). (e) Oligomer disaggregation upon dilution into aqueous buffer to 280 pM 
(n = 3, std). (f) Comparative dose-response assay of Proteinase K digestion (n = 3, std).
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certain α S aggregates42. We have recently observed a rapid in vitro degradation of α S monomers independently of 
ubiquitin modification, and found that α S oligomers with a specific type of ubiquitin modification alter the struc-
tural properties to enable direct proteasomal degradation (Y. Y.). In order to compare the susceptibilities of the 
ARA-induced oligomers and the α S-only oligomers towards degradation by the proteasome, comparative assays 
were carried out, using identical degradation mixtures and incubation conditions for both kinds of oligomers 
and exposing both types of aggregates to mammalian 26S proteasome for a period of 12 hours (Fig. 3d). Over this 
selected incubation time, the numbers of ARA-induced oligomers were reduced upon proteasome-treatment. In 
contrast, the samples lacking ARA were not targeted by the proteasome, in agreement with the previous literature. 
This suggested that ARA-induced oligomers were more degradable by proteasome in comparison to the α S-only 
oligomers.
To confirm that ARA-induced oligomers were less stable than α S-only oligomers, we carried out oligomer 
disaggregation experiments, where the oligomeric samples were diluted to single-molecule concentrations into 
buffer, and left under quiescent conditions for several hours. During this time, the decrease in the numbers of 
oligomers due to their dissociation into monomers in solution was monitored by sm-FRET (Fig. 3e). While the 
decrease in the numbers of oligomers was observed for both the ARA-induced oligomers and the oligomers 
formed in its absence, it was faster for the former species confirming the previous findings of their lower stabil-
ity. This difference points towards structural differences of the ARA-induced oligomers compared to α S-only 
oligomers.
To gain further information about this difference, comparative proteolytic digestion assays were carried out, 
by exposing both the ARA-induced oligomers and the oligomers formed in the absence of ARA to varying con-
centrations of Proteinase K (PK) enzyme (Fig. 3e). Our previous studies showed that high resistance to PK diges-
tion was characteristic for beta-sheet conformation in α S aggregates, and amyloid fibrils were the most resistant 
in this assay35. Here, both types of oligomers were susceptible to PK digestion; however, the fractions of remaining 
non-digested oligomers were consistently higher in the samples containing α S-only oligomers, additionally indi-
cating that the ARA-induced oligomers were less stable, consistent with the lack of beta-sheet structure in these 
aggregates.
Lastly, we investigated whether ARA itself was a constituent of the ARA-induced oligomers. Due to 
the observed tendency to assemble into large agglomerates (Fig. 2b), it was presumed that the association of 
ARA-induced oligomers into larger aggregates could occur via the free fatty acid molecules, and we set out to 
test whether these species could remain stable upon decreasing the concentration of ARA in solution. To address 
this, ARA- and α S-containing samples were prepared as described above, and the concentration of the acid was 
decreased by washing with the excess of aqueous buffer and by subsequently concentrating the protein solutions, 
as described in Methods. This resulted in the increase in the numbers of recovered oligomers (Fig. 4a), as well as 
an 11 ± 5% increase in the population of small species consisting of less than 6 apparent monomer units, and a 
drop in the sub-population of larger oligomers (Fig. 4b). This indicated that the multimers had undergone a par-
tial dissociation during the process (Fig. 4b), suggesting that the excess of fatty acid molecules acts to stabilize the 
larger multimers. Nevertheless, the finding that the majority of the aggregates could be recovered and remained 
sufficiently stable to be detected at picomolar concentrations of the protein in the sm-FRET experiments implies 
a degree of stability, and indicates a strong binding of ARA to α S in these aggregates. These observations are 
compatible with the previous reports of the stability of the FA-induced multimers of α S upon chromatographic 
procedures23,29, and highlight a challenge of removing FAs from α S under these conditions. The result that the oli-
gomers partially dissociated upon the decrease of FA suggests that ARA is a stabilizing constituent of these aggre-
gates, which is consistent with previous related findings that α S co-aggregated with anionic lipids43. Consistent 
with this, the CD spectrum of α S solution, recorded after decreasing the concentration of ARA, indicated that the 
alpha-helical conformation was preserved in the samples (Fig. 4c).
ARA-induced oligomers of αS are less damaging to cells than oligomers formed in its absence. 
In order to further compare ARA-induced oligomers with the oligomers formed in its absence, we investigated 
their relative abilities to cause cell damage. We have previously reported that α S oligomers that are generated 
in aqueous buffer under constant shaking can promote the production of reactive oxygen species (ROS) when 
applied to primary neuronal cultures35. To assess the extent of ROS production promoted by ARA-induced oli-
gomers, we measured the production of superoxide induced by their application to primary cultures of cor-
tical neurons by quantifying the rate of oxidation of the dye dihydroethidium, as detailed in Methods and 
Supplementary Information, and shown in Fig. 4d. In these experiments, α S oligomers (500 nM total α S) pre-
pared in the absence of ARA lead to the highest significant increase in the production of ROS relative to the basal 
level, 222 ± 12.95% compared to 100% basal (P < 0.01), in agreement with our previous reports35,38. In contrast, 
application of the same concentration of ARA-induced oligomers after the depletion of excess free ARA produced 
a smaller increase in ROS, 134 ± 7.78% in comparison to the 100% basal level (P < 0.05), which was significantly 
reduced in comparison to what was shown by oligomers prepared in the absence of ARA (P < 0.01). As controls, 
we utilized ARA alone and ARA-induced oligomers without depletion of ARA, and in both cases again observed 
only a small increase in ROS production over basal levels (P < 0.05) (Fig. 4d).
In addition, we investigated the ability of ARA-induced α S oligomers to promote cell death, as described in 
Methods and Supplementary Information. Representative images from these experiments are in Supplementary 
Fig. 5. We found that the incubation of cells overnight with α S oligomers generated in aqueous buffer induced 
a significant increase in cell death (P < 0.05), as detailed in Fig. 4e, corroborating their previously established 
neurotoxic nature35. Conversely, incubation of cells with ARA-induced oligomers did not induce a significant 
increase in basal levels of cell death, shown in Fig. 4e. We observed that free ARA was able to cause cell damage in 
both of these assays, particularly upon longer incubations presumably due to its oxidation, while ARA-induced 
oligomer samples after depletion of the excess of ARA were benign in the cell death assay. Overall, these results 
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suggest that ARA-induced oligomers are less toxic to the cortical neurons than α S oligomers generated in its 
absence, particularly under the conditions when excess free ARA is rapidly depleted. This result may have physi-
ological relevance, given that free ARA is known to be highly transient in vivo44.
Furthermore, we tested whether ARA-induced oligomers could lead to a reduced pro-inflammatory activation 
of microglia relative to the α S oligomers prepared in its absence. Growing evidence suggests that the activation 
of microglia is linked to the progression of neurodegeneration in synucleophathies45. We assessed the response 
of microglia by measuring the concentration of secreted tumor necrosis factor alpha (TNF-α ) protein, which is 
one of the major pro-inflammatory cytokines that is released by microglia upon their activation, and has been 
shown to promote α S-induced cell death46. In these experiments, detailed in the Methods section, the secretion 
of TNF-α was found to be consistently higher in response to the oligomers formed in aqueous buffer than in 
response to the ARA-induced oligomers, and this difference was clearly observed at a broad range of applied total 
concentrations of α S (Fig. 4f).
ARA-induced oligomer formation at physiologically-relevant concentrations of αS and 
ARA. In the above experiments ARA has been used at high concentration above its CMC value26,39. Because 
ARA is a biologically relevant molecule and occurs in vivo at concentrations significantly below its CMC, we 
Figure 4. ARA depletion experiments and comparative cell assays. (a) Numbers of oligomers, detected by 
sm-FRET before and after decreasing the concentration of ARA by washing with excess buffer (see Methods) 
(n = 3, std). (b) The increase in the smallest oligomers (2-5-mers) is observed, whereas the fraction of larger 
species drops, indicating that oligomers undergo a partial dissociation upon separation from the acid. (c) CD 
spectrum acquired after washing the protein sample, showing that the alpha-helical conformation is preserved. 
The detection of intact small multimers and alpha-helical conformation indicate that ARA is still present in 
solution and bound to α S in these multimers. Thus, it is very difficult to fully separate the FA from α S under 
these conditions. (d) Cytoplasmic ROS production by monitoring the rate of the ratio of the oxidised to reduced 
form of dihydroethidium (n = 50–90 cells, sem). Application of α S oligomers (500 nM of total α S) lead to a 
significant increase in ROS production (222 ± 12.95% compared to 100% basal, n =  88 cells, P < 0.01 relative 
to basal level). Application of ARA-induced oligomers (500 nM of total α S) showed small increase in ROS 
generation (134 ± 7.78%, n = 73 cells, P < 0.05 relative to basal level). Application of washed ARA-induced 
oligomers after ARA depletion by centrifugation (500 nM of total α S) or application of ARA alone (14.2 μ M 
ARA) produced close to basal levels of ROS. (e) Percentage of cell-death as measured by Hoechst/propidium 
iodide staining after overnight incubation with the α S-only or ARA-induced oligomers, or ARA (n = 6–9 fields 
of view, sem). α S-only oligomers caused an increased cell death (7.54 ± 1.57%, n(cells)  =  693, P < 0.05 relative 
to untreated group), while ARA-induced oligomers washed from excess ARA lead to basal levels of cell death 
(1.3 ± 0.52%, n  =  7 fields of view, n(cells) = 509). (f) Pro-inflammatory response measured by the production 
of THF-α in BV2 microglia after a 24-h incubation of the cells after treatment with α S-only oligomers, ARA-
induced oligomers and ARA alone, added at a range of concentrations between 0.05–200 μ M (n = 4, sem).
www.nature.com/scientificreports/
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extended our study to more physiologically-relevant concentrations of 2–10 μ M47 (Supplementary Fig. 6a). In 
addition, the concentrations of α S protein at the synapse were reported to be in the range 2–5 μ M11. Therefore, 
in order to mimic the concentrations of both α S and ARA found in vivo, we combined 2 μ M α S and 10 μ M ARA. 
Under these conditions, a rapid multimerization was still observed shortly after the addition of ARA, as shown 
in Fig. 5a, and an increase in their numbers was present during the first 6 hours, resembling the timescales of the 
process at higher concentrations (Fig. 1a). The numbers of the detected oligomers, and their estimated concen-
trations (Supplementary Fig. 6b) were lower in comparison to the results in the high-concentration experiments, 
Figure 5. Experiments using physiological concentrations of αS and ARA. (a) Kinetic profile of oligomer 
formation at 2 μ M α S in the presence of 10 μ M ARA (dashed line), and in the absence of ARA under the same 
conditions (black line) (n = 3, std). (b) Comparison of apparent size distributions at 35 μ M α S with 1 mM ARA 
(red), or 2 μ M α S with 10 μ M ARA (black). (c) Representative FRET efficiency histograms, resulting from sm-
FRET analysis of the oligomers formed with either 35 μ M α S with 1 mM ARA, or 2 μ M α S with 10 μ M ARA 
after 6 h. After this and later times, there was no difference in the appearance of the histograms, apart from 
lower total numbers detected in the lower-concentration samples, when the same protein concentration was 
used for the detection. (d) CD spectra of the solutions of 2 μ M α S with 10 μ M ARA after 24 h and enrichment 
using 100 kDa spinfilter. (e) Overlaid oligomer disaggregation profiles upon dilution into aqueous buffer to 
280 pM of 35 μ M α S samples with 1 mM ARA (red), and 2 μ M α S with 10 μ M ARA (grey) (n = 3, std).  
(f) Numbers of oligomers detected after > 30 h using a range of α S isoforms, either A90C or pathological 
mutants, at 2 μ M with 10 μ M ARA (grey) or in the absence of ARA (red) (n = 6, sem).
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which highlights the challenge of monitoring this low-concentration process using more conventional bulk meth-
ods. Despite the lower overall numbers of oligomers, the growth of these species was again observed, with similar 
apparent size distributions compared to the higher-concentration reaction (Fig. 5b), and very similar FRET effi-
ciency histograms (Fig. 5c). Further, we used CD to determine the conformation of these multimers. Preliminary 
attempts to measure the solutions containing 2 μ M α S and 10 μ M ARA resulted in the spectra indicating the 
presence of intrinsically disordered protein. This was consistent with the single-molecule observations that even 
though the multimers were present in the solutions, the majority of α S was still in its monomeric form, as is indi-
cated by the low estimated concentrations of the multimers (Supplementary Fig. 6b). We therefore enriched the 
multimers using 100 kDa spin-filters, as described in Methods, and their CD spectrum indicated that these spe-
cies were alpha-helically-folded, similarly to the species generated at 35 μ M α S with 1 mM ARA (Fig. 5d). To note, 
the retention by the 100 kDa cutoff filter is consistent with the oligomers being the size of a tetramer and larger.
Based on these results, it could be concluded that the preparation at 2 μ M α S and 10 μ M ARA yielded the 
same species as the higher-concentration preparation, even though the overall number of multimers was low at 
these physiologically-relevant concentrations. To confirm this conclusion, we monitored the disaggregation of 
the low-concentration multimers, by diluting the samples to single-molecule concentrations and recording the 
decrease in their numbers over time due to their dissociation. The resulting disaggregation profiles were similar 
to the ones obtained for the high-concentration preparations at 35 μ M α S and 1 mM ARA, as shown in Fig. 5e.
In order to test whether disease-associated point mutations of α S could lead to the self-assembly upon the 
action of ARA, we prepared the samples using 2 μ M α S as well as 2 μ M A30P, A53T and E46K mutants of α S, with 
the addition of 10 μ M ARA. As a result, the formation of oligomers was observed for α S, as before. In the case of 
the mutants, however, the samples contained more aggregates than the wild-type (A90C) protein in the absence 
of ARA, and the presence of ARA had less effect on the number of aggregates, as shown in Fig. 5f. Thus, at the 
chosen conditions, the effect of ARA was comparable between wild-type α S and E46K mutant, and much less 
apparent for the pathological mutants A30P and A53T in comparison to the wild-type α S.
Discussion
In this study, we have generated alpha-helical multimers of α S in the presence of ARA, and demonstrated their 
clear differences compared to the toxic beta-sheet-rich oligomers of α S, characterized in our previous works35,38. 
ARA-induced oligomers differed from the oligomers generated in the absence of ARA in both morphology and 
size, displayed lower stability towards the changes in buffer conditions and had a higher propensity to disassem-
ble upon sample dilutions. In addition, they were more susceptible to enzymatic digestion and degradation by 
proteasome. Despite their apparent lower stability in comparison to the α S-only oligomers, we found that these 
multimers could preserve their conformation upon the reduction of ARA concentration, which is particularly 
significant considering that ARA is highly transient in vivo44.
The ARA-induced oligomers in our experiments were evidently distinct from the beta-sheet-rich oligomers 
formed during the aberrant aggregation of α S. Moreover, they were resistant to fibril formation, as judged from 
TEM imaging, and required ARA for their stabilization, as concluded from the ARA washing experiments. These 
species may therefore represent the products of an alternative reaction involving both α S and ARA, as is sche-
matically illustrated in Fig. 6. Because their formation is fast and recruits monomeric α S, it can compete with the 
slow formation of high-FRET beta-sheet oligomers particularly when the total monomer concentration is low. We 
Figure 6. Schematic outline of the self-assembly mechanisms of αS in the absence and in the presence of 
ARA. (a) Without ARA, monomeric protein assembles according to the aberrant aggregation mechanism, as 
reported previously38. In this mechanism, α S forms disordered low-FRET oligomers, which convert to toxic 
and beta-sheet-rich high-FRET oligomers, which in turn convert into fibrils. (b) Upon the addition of ARA, the 
alpha-helical ARA-induced multimers are formed, comprising both α S and ARA. Equilibrium with monomer 
is consistent with the immediate ARA-induced oligomer formation, and equilibrium with low-FRET oligomers 
can account for the observed time-progression during first 6 hours of the reaction.
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previously showed that the beta-sheet-rich oligomers of α S were the most cytotoxic species35 and caused damage 
to neuronal cells when present even at picomolar concentrations38, and reconfirmed their toxicity in the present 
study. Therefore, any competing mechanisms that inhibit their formation may be highly neuroprotective. This 
is consistent with the finding that disease-associated mutants of α S had a lower tendency to assemble into the 
FA-induced species compared to the wildtype α S, which leaves them in a free state and may ultimately lead to the 
generation of higher concentrations of toxic beta-sheet-rich oligomers via the aberrant aggregation mechanism. 
To note, this in vitro result is in striking agreement with what was shown for PD mutants of α S in intact neurons 
by both cell-penetrant crosslinking and fluorescent protein complementation48.
Considering the remarkable ease of formation of the ARA-induced multimers and their stability under 
physiologically relevant concentrations, it can be argued that the formation of closely-related multimers may 
potentially occur in vivo. In line with this, multiple properties of the ARA-induced oligomers show close resem-
blance to the native alpha-helical multimers of α S extracted ex vivo9,10 such as being small, below 10-mers, 
alpha-helically-folded and aggregation-resistant. In our experiments, these multimers were present in the excess 
of monomeric α S, which was concluded from the observation of an excess of monomeric bursts in addition to the 
multimers during sm-FRET measurements (Supplementary Fig. 1), and from the CD spectra of the flow-through 
after their enrichment (Fig. 5d). This may suggest that these species are in equilibrium with monomeric α S, sim-
ilarly to what was proposed for the native multimers27,48.
Clearly, although ARA has been used in the present study, numerous polyunsaturated FAs and their mixtures 
in vivo may play a similar role to facilitate the formation and stabilization of aggregation-resistant alpha-helical 
multimers of α S. This may contribute towards the reduction in cytotoxicity associated with these FAs49,50 in the 
context of PD and related disorders. Given the strong biophysical evidence for the formation of alpha-helical 
multimers of α S in the presence of ARA in our study, we therefore suggest that ARA and other polyunsaturated 
FAs may be the unidentified stabilizing co-factors for the native multimers of α S, suggested previously51. Thus, 
polyunstaturated FAs may play a crucial role in α S homeostasis via the stabilization of native multimers and the 
prevention of aberrant aggregation of α S.
Methods
Reagents. ARA, Trizma base, NaCl, CaCl2. Proteinase-K, THT and propidium iodide were purchased from 
Sigma Aldrich. Hoechst 33342 was from Molecular Probes. Alexa Fluor 488 C5 maleimide and Alexa Fluor 594 
C5 maleimide dyes were from Life Technologies.
ARA solution preparation. ARA was stored under nitrogen at –80 °C, and aqueous stock solutions were 
freshly prepared prior to all experiments by adding the pure FA to ice-cold buffer (25 mM Tris, 0.2 M NaCl) fol-
lowed by vigorous agitation.
α-Synuclein preparation. α S wild-type and A90C were expressed as previously described52. A90C was 
labeled with maleimide-linked Alexa Fluor 488 (AF488) or Alexa Fluor 594 (AF594) and separated from the 
unreacted dyes as previously reported35,38. The protein aliquots were stored at − 80 °C and thawed once before use.
α-Synuclein aggregation. For the preparations of α S oligomers in the absence of ARA, a 35 μ M pro-
tein solution was made, containing 1:1 stoichiometric ratios of AF488- and AF594-labeled α S in Tris buffer 
(25 mM Tris, 0.1 M NaCl, pH 7.4), with 0.01% NaN3, and a total sample volume was 300 μ L. The buffer in all 
single-molecule experiments was pre-filtered using 0.02 μ m syringe filter (Anotop, Whatman). The aggrega-
tion mixture was incubated in the dark over 24 h at 37 °C with constant shaking at 200 r.p.m. (New Brunswick 
Scientific Innova 43, 25 mm orbital diameter), and subsequently centrifuged at 14.2 r.p.m. for 15 min and sepa-
rated from fibrillar pellet.
For the preparations of ARA-induced oligomers of α S, an aggregation mixture contained 1:1 ratio of AF488- 
and AF594-labeled α S, with the total α S concentration of 35 μ M, and 1 mM concentration of ARA, by diluting 
into Tris buffer (25 mM Tris, 0.1 M NaCl, pH 7.4) and 0.01% NaN3, with the total volume of 300 μ L. The mixture 
was incubated in the dark over 24 hours at 37 °C without agitation.
sm-FRET measurements and data analysis. Single-molecule confocal setup, the experimental proce-
dure and data analysis were similar to previously reported38, and are detailed in Supplementary Information. 
FRET efficiency values were calculated according to
γ
=
+
E I
I I( ) (1)
A
A D
where ID is the corrected donor fluorescence intensity, IA is the corrected acceptor intensity and γ is a gamma 
factor (0.99) specific to the instrument. FRET efficiency values were represented as histograms with a bin-width 
of 0.05 (Fig. 3a). Oligomer apparent size was estimated using
γ
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where IDmonomer was the average intensity of fluorescence bursts in the donor channel after exclusion of oligo-
meric bursts. In this equation, the total fluorescence intensity from AF488 (numerator) is normalized by the 
average AF488 monomer brightness. The factor of two corrects for the 1:1 stoichiomerty of AF488 and AF594 
fluorophores. Species occupying multiple consecutive time-bins or determined to be greater than 150-mers were 
assumed to be either fibrillar or arising from dust, and removed from the analysis36. The expression is valid under 
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the assumption that there is no appreciable quenching in the soluble oligomers, as was demonstrated in our pre-
vious work35. Note that the size distributions are referred to as “apparent”, serving as estimates owing to the sto-
chastic nature of fluorescence emission and different paths the oligomers can take through the confocal volume.
In order to determine the average FRET efficiency value, the FRET histograms of selected timepoints were 
fitted to either a single or a double Gaussian distribution, depending on the presence of either one of two peaks, 
using GaussAmp functions:
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where A and A2 are the amplitudes, xc and xc2 the centers, corresponding to average FRET efficiency values (E), 
w and w2 the widths of the distributions. The representative fitted histograms are shown in Fig. 3a.
CD measurements. For experiments in Fig. 1c, samples were prepared in the same way as for the sm-FRET 
experiments, using AF594-labeled α S, and diluted into Tris buffer to the final protein concentrations of 3–10 μ M 
prior to the measurements. CD spectra were recorded on Jasco J-810 spectropolarimeter, using a quarz cuvette of 
1 mm. The spectra were acquired between 205 and 250 nm, with an interval of 0.2 nm, and an average of 10 accu-
mulations per spectrum, using 1 nm bandwidth and a scanning speed of 50 nm/min. The spectra were corrected 
for the background from the buffer in the case of α S in buffer samples, and for the background from the buffer 
with ARA, for the samples containing ARA. FFT smoothing with a window of 25 datapoints was applied (Origin), 
and the resulting spectra were presented as millidergees versus wavelength. For experiments in Fig. 5d, samples 
containing 2 μ M α S (1:1 AF488- α S and AF594- α S) and 10 μ M ARA at a total volume of 300 μ L were incubated 
for 24 h under the same conditions as before. Subsequently, 10 samples (3 mL) were combined and centrifuged 
in a filter device with a molecular cut-off of 100 kDa (Amicon Ultra, Millipore). It was expected that some of the 
ARA-induced oligomers would remain on top of the filter resulting in the multimer-enriched sample. The specta 
of both flow-through and the solution remaining on the filter were acquired using the same spectrometer and 
settings as before, between 200 and 250 nm and 20 accumulations per spectrum. The spectra were corrected for 
the background from buffer. No additional smoothing was applied, and the result was expressed as millidegrees 
versus wavelength. For the measurement in Fig. 4c (of the samples washed with buffer to remove excess ARA), 
the protein concentration was 4 μ M, the spectrum was recorded using identical setting as above, with 20 accumu-
lations per spectrum, and the spectrum of buffer was subtracted from the spectrum of the sample.
TEM Imaging. For TEM imaging (Fig. 2), the sample preparation was the same as for sm-FRET experi-
ments, and the samples were imaged after 24 h of incubation. 10 μ L volumes of the samples were applied onto 
carbon-coated 400-mesh copper grids (Agar Scientific) for 5 min, and washed with double distilled water. 
Negative staining was carried out by using 2% (w/v) uranyl acetate. TEM images were acquired using Tecnai G2 
microscope (13218, EDAX, AMETEK) operating at an excitation voltage of 200 kV.
Oligomer stability at different ionic strengths. It was recently demonstrated using the sm-FRET 
method that α S oligomers had differential stabilities depending on the ionic strength of buffer solutions36. To 
compare the stability of the ARA-induced oligomers and α S oligomers formed in pure buffer with respect to the 
changes in ionic strength, the samples after 24 h of incubation were diluted 1:100,000 into either Tris, Tris/2 (Tris 
buffer diluted with MQ water), Tris/4, Tris/8 and Tris/16, and analyzed by sm-FRET immediately after dilution 
(Fig. 3c).
Proteasome degradation assays. Mammalian 26S proteasomes were purified from HEK293T cells over-
expressing rpn11-His-TEV-biotin acceptor sequence (kind gift from Lan Huang, UC Irvine) and purified using 
established protocols53,54. Cells were grown until 100% confluent and collected and resuspended with a scraper in 
ice-cold Proteasome buffer (50 mM Tris, pH 7.5, 0.5% NP-40, 10% glycerol, 5 mM ATP, 1 mM DTT, 5 mM MgCl2). 
Dounce homogenizer was then used for cell lysis and the lysate was cleared by centrifugation at 3000 × g for 5 min 
at 4 °C. This lysate was subsequently incubated with 2 ml bed volume of NeutrAvidin beads (Pierce) at 4 °C over-
night. Unbound proteins were washed off with 20 ml proteasome buffer and bound proteasomes were cleaved 
off the column with 6 μ l of TEV protease (Invitrogen). Proteasomes were concentrated to > 2 μ M and frozen in 
aliquots for single use. For the comparison between the ARA-induced oligomers and α S oligomers formed in 
pure Tris buffer with respect to their stability towards degradation by 26S proteasome, samples containing 35 μ M 
α S in buffer, or 35 μ M α S plus 1 mM ARA after 24 h of incubation were diluted 1:3.75 for proteasomal degradation. 
The final assay contained 40 nM proteasome, 125 mM ATP.MgCl2, 5 μ M creatine kinase and 0.1 M creatine 
phosphatase in 50 mM Tris buffer (pH 7.4). The resulting samples were analyzed by sm-FRET both immediately 
after mixing, and after incubation for 12 h under quiescent conditions at 37 °C. The fractions of non-degraded 
oligomers were determined as the numbers of oligomers after the incubation divided by the numbers of oligomers 
immediately after mixing (Fig. 3d).
Oligomer disaggregation upon dilution. To further compare the stabilities of ARA-induced oligomers 
and oligomers of α S formed in pure buffer, both types of samples after 24 h of incubation were diluted 1:100,000 
into Tris buffer of the same composition as for the aggregations, incubated at quiescent conditions at ambi-
ent temperature in low-binding test-tubes (Protein LoBind, Eppendorf), and regular aliquots were analyzed by 
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sm-FRET over 7 h after dilution, ensuring that the aliquots were withdrawn for the analysis at the same incubation 
time for either type of samples, to allow a comparison of the disaggregation reactions (Fig. 3e). The same exper-
iment was carried out using ARA-induced oligomers prepared at 2 μ M α S and 10 μ M ARA, and compared with 
the disaggregation profiles of the ARA-induced oligomers generated at high concentration, as show in Fig. 4e.
Proteinase-K digestion assays. To carry out further structural comparison between the ARA-induced 
oligomers and α S oligomers formed in pure Tris buffer, their susceptibility to Proteinase-K (PK) digestion was 
investigated (Fig. 3f). Beta-sheet structure, present in fibrils and high-FRET oligomers, is resistant to PK diges-
tion, as was shown in our previous works35. PK aliquots were prepared in Tris buffer defined above, with the 
addition of 1 mM CaCl2, and stored at − 80 °C before use. Samples after 24 h incubation were diluted into a range 
of PK concentrations between 0–10 μ g/ml in Tris buffer with 1 mM CaCl2. incubated at 37 °C for 5 min, and sub-
sequently further diluted for the sm-FRET analysis.
Depletion of ARA concentration. ARA-induced oligomers were prepared as described above, and subse-
quently the concentration of free ARA was decreased by washing with copious amounts of buffer, and the protein 
was concentrated using a spin filter with a molecular cutoff of 5 kDa (Sartorius). Based on the total volume of 
buffer used for washing in this experiment, the concentration of ARA would be reduced to less than 500 nM. Note 
that this estimation is a lower bound and does not account for the ARA binding to α S. This preparation is referred 
to as “ARA washed” in Fig. 4.
Cell culture. Mixed cultures of cortical neurons and glial cells were prepared and cultured as described 
previously55. The BV2 cell lines were derived from immortalized murine neonatal microglia. They were grown 
and incubated at 37 °C in a humidified atmosphere of 5% CO2 and 95% air, until ~300,000 cell/ml.
Protein sample preparation for the cell assays. For the assays, unlabeled wild-type α S was used instead 
of dual-labeled samples in order to ensure the absence of fluorescence emission from AF labels. Protein sample 
preparation protocol was identical to the procedures for sm-FRET experiments. The solutions after 24-h incuba-
tion were applied on cells at the same total concentration of α S, and at the corresponding concentration of ARA.
ROS measurements. The experiments (Fig. 4d) were carried out according to previously detailed proto-
cols35 as detailed in Supplementary Information, and involved measurements within first 10 minutes upon the 
sample application to the cell cultures.
Cell death assays. In these experiments (Fig. 4e) α S and ARA solutions were applied to primary co-cultures 
overnight at 37 °C. The cells were loaded simultaneously with 20 μ M propidium iodide, which is excluded from 
viable cells but exhibits red fluorescence following a loss of membrane integrity, and 10 μ M Hoechst 33342 
(Molecular Probes), which gives blue staining to chromatin, and the total number of dead cells was counted, as 
further detailed in Supplementary Information and Supplementary Fig. 5.
Quantification of TNF-α production. The experiments in Fig. 4f were carried out using BV2 microglia. 
α S-only and ARA-induced oligomer solutions as well as free ARA were prepared and applied at a range of con-
centrations from 0.05–200 μ M of α S. After application, the cells were incubated at 37 °C for 24 h, and the super-
natants were subsequently collected and analyzed using TNF-α Elisa kit (R & D, Minneapolis, MN) according to 
manufacturer’s protocol. In this assay, an increase in TNF-α due to free ARA (59.673 pg/mL) could be detected 
only upon application of excess ARA (1 mM) and 5-d incubation.
Statistical analysis of the data from cell experiments. Student t-tests were carried out using Origin 9 
software (Microcal Software) and the resulting p values are reported in the legend of Fig. 4.
Comparison of ARA-induced multimerisation using pathological mutants of αS. In order to 
investigate whether the formation of ARA-induced oligomers could be observed at low concentrations when 
using pathological mutants of α S, dual-labelled A90C α S was used, and dual-labelled A30PA90C, A53TA90C 
and E46KA90C α S variants, denoted as A30P*, A53T* and E46K* in Fig. 4f, where ‘*’ indicates that these iso-
forms carry the A90C mutation for the fluorophore incorporation in addition to the disease-associated mutation. 
The pathological mutants were expressed and purified as previously described in detail. Samples of 2 μ M α S of 
every isoform in the presence of 10 μ M ARA, or in its absence (6 separate samples in each case) were prepared 
and incubated at 37 °C without shaking for > 30 h to allow steady-state aggregate populations, and subsequently 
analysed by sm-FRET, keeping the protein concentration for the detection the same for all samples, as judged by 
comparing the monomer burst rates. Numbers of detected aggregates were compared (Fig. 5f).
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